These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 22037388)

  • 21. A novel tool to assess systolic asynchrony and identify responders of cardiac resynchronization therapy by tissue synchronization imaging.
    Yu CM; Zhang Q; Fung JW; Chan HC; Chan YS; Yip GW; Kong SL; Lin H; Zhang Y; Sanderson JE
    J Am Coll Cardiol; 2005 Mar; 45(5):677-84. PubMed ID: 15734610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy.
    Bax JJ; Bleeker GB; Marwick TH; Molhoek SG; Boersma E; Steendijk P; van der Wall EE; Schalij MJ
    J Am Coll Cardiol; 2004 Nov; 44(9):1834-40. PubMed ID: 15519016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-dose dobutamine echocardiography predicts recovery of left ventricular systolic function following revascularization even in presence of low contractile reserve.
    Kasliwal RR; Paul B; Mustaqueem A; Bansal M; Trehan N
    Indian Heart J; 2006; 58(2):120-5. PubMed ID: 18989055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional behavior of patients with conventional pacemakers undergoing cardiac resynchronization.
    Silva RT; Martinelli Filho M; Lima CE; Martins DG; Nishióka SA; Pedrosa AA; Crevelari ES; Costa R; Sosa EA; Ramires JA
    Arq Bras Cardiol; 2008 Feb; 90(2):138-43. PubMed ID: 18392387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.
    Bonanno C; Ometto R; Pasinato S; Finocchi G; La Vecchia L; Fontanelli A
    Ital Heart J; 2004 May; 5(5):364-70. PubMed ID: 15185900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
    Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C;
    J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Importance of contractile reserve for CRT.
    Lim P; Bars C; Mitchell-Heggs L; Roiron C; Elbaz N; Hamdaoui B; Lellouche N; Dubois-Randé JL; Guéret P
    Europace; 2007 Sep; 9(9):739-43. PubMed ID: 17573360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Remission of left ventricular systolic dysfunction and of heart failure symptoms after cardiac resynchronization therapy: temporal pattern and clinical predictors.
    Gasparini M; Regoli F; Ceriotti C; Galimberti P; Bragato R; De Vita S; Pini D; Andreuzzi B; Mangiavacchi M; Klersy C
    Am Heart J; 2008 Mar; 155(3):507-14. PubMed ID: 18294488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myocardial contractile reserve during exercise predicts left ventricular reverse remodelling after cardiac resynchronization therapy.
    Lancellotti P; Senechal M; Moonen M; Donal E; Magne J; Nellessen E; Attena E; Cosyns B; Melon P; Piérard L
    Eur J Echocardiogr; 2009 Jul; 10(5):663-8. PubMed ID: 19351652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-dose dobutamine stress echocardiography to assess left ventricular contractile reserve for cardiac resynchronization therapy: data from the Low-Dose Dobutamine Stress Echocardiography to Predict Cardiac Resynchronization Therapy Response (LODO-CRT) trial.
    Iacopino S; Gasparini M; Zanon F; Dicandia C; Distefano G; Curnis A; Donati R; Neja CP; Calvi V; Davinelli M; Novelli V; Muto C
    Congest Heart Fail; 2010; 16(3):104-10. PubMed ID: 20557329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of left ventricular endocardial activation pattern on echocardiographic and clinical response to cardiac resynchronization therapy.
    Fung JW; Chan JY; Yip GW; Chan HC; Chan WW; Zhang Q; Yu CM
    Heart; 2007 Apr; 93(4):432-7. PubMed ID: 17237127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-dose dobutamine stress echo to quantify the degree of remodelling after cardiac resynchronization therapy.
    Parsai C; Baltabaeva A; Anderson L; Chaparro M; Bijnens B; Sutherland GR
    Eur Heart J; 2009 Apr; 30(8):950-8. PubMed ID: 19269987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced atrial tachyarrhythmia susceptibility after upgrade of conventional implanted pulse generator to cardiac resynchronization therapy in patients with heart failure.
    Yannopoulos D; Lurie KG; Sakaguchi S; Milstein S; Ermis C; VanHeel L; Benditt DG
    J Am Coll Cardiol; 2007 Sep; 50(13):1246-51. PubMed ID: 17888841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does presence of left ventricular contractile reserve improve response to cardiac resynchronization therapy? An updated meta-analysis.
    Papageorgiou N; Providência R; Lambiase PD; Tousoulis D; Lloyd G; Bhattacharyya S
    Int J Cardiol; 2018 Feb; 252():224-228. PubMed ID: 29249433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recoordination rather than resynchronization predicts reverse remodeling after cardiac resynchronization therapy.
    Wang CL; Wu CT; Yeh YH; Wu LS; Chang CJ; Ho WJ; Hsu LA; Luqman N; Kuo CT
    J Am Soc Echocardiogr; 2010 Jun; 23(6):611-20. PubMed ID: 20418055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contractile reserve induced with dobutamine echocardiography predicts outcome in patients with left ventricular dysfunction and mitral regurgitation.
    Moss RR; Bar SL; Chandavimol M; Munt B; Thompson CR; Abel JG; Humphries K; Ignaszewski AP
    J Heart Valve Dis; 2014 Mar; 23(2):177-83. PubMed ID: 25076548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diastolic asynchrony is more frequent than systolic asynchrony in dilated cardiomyopathy and is less improved by cardiac resynchronization therapy.
    Schuster I; Habib G; Jego C; Thuny F; Avierinos JF; Derumeaux G; Beck L; Medail C; Franceschi F; Renard S; Ferracci A; Lefevre J; Luccioni R; Deharo JC; Djiane P
    J Am Coll Cardiol; 2005 Dec; 46(12):2250-7. PubMed ID: 16360054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction between two predictors of functional outcome after revascularization in ischemic cardiomyopathy: left ventricular volume and amount of viable myocardium.
    Mandegar MH; Yousefnia MA; Roshanali F; Rayatzadeh H; Alaeddini F
    J Thorac Cardiovasc Surg; 2008 Oct; 136(4):930-6. PubMed ID: 18954632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of LOw-dose DObutamine stress-echocardiography to predict cardiac resynchronization therapy response (LODO-CRT) multicenter prospective study: design and rationale.
    Muto C; Gasparini M; Iacopino S; Peraldo C; Curnis A; Sassone B; Diotallevi P; Davinelli M; Valsecchi S; Tuccillo B
    Am Heart J; 2008 Oct; 156(4):656-61. PubMed ID: 18926147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence, clinical characteristics, quality of life, and prognosis of patients with congestive heart failure and isolated left ventricular diastolic dysfunction.
    Badano LP; Albanese MC; De Biaggio P; Rozbowsky P; Miani D; Fresco C; Fioretti PM
    J Am Soc Echocardiogr; 2004 Mar; 17(3):253-61. PubMed ID: 14981424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.